Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00154141 · ClinicalTrials.gov registry record · Phase 3

Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

A Phase 3 study, sponsored by Ethicon.

Completed
Registry status
Phase 3
Development phase
150
Enrollment target

NCT00154141: Completed Phase 3 study, sponsored by Ethicon.

NCT00154141 is a Phase 3 study that has completed, run by Ethicon. The registered enrollment target is 150 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00154141, a Phase 3 study, has completed, sponsored by Ethicon.

COMPLETED
Registry status
Phase 3
Development phase
150 participants
Enrollment target

Study Summary

A comparison of a fibrin sealant versus manual compression in stopping surgical bleeding during vascular procedures.

Interventions

  • DRUG Fibrin sealant (FS2)

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2005-06
Est. Completion 2006-03
Phase Phase 3
Ethicon

38 total trials

What the finished NCT00154141 record still lists

NCT00154141 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Fibrin sealant (FS2) is the first listed.

NCT00154141 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00154141 about?

NCT00154141 is a clinical study titled "Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures". A comparison of a fibrin sealant versus manual compression in stopping surgical bleeding during vascular procedures.

What is the current status of trial NCT00154141?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2005-06. Estimated completion is 2006-03.

What interventions are being tested in trial NCT00154141?

The interventions under investigation include: Fibrin sealant (FS2) (DRUG).

Who is sponsoring clinical trial NCT00154141?

This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00154141's enrollment target sits among peer trials

150 1519th of 2000 higher than 455 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00154141, the US trial registry maintained by the National Library of Medicine. NCT00154141 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.